Last updated on August 2009

Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary


Brief description of study

RATIONALE: New diagnostic procedures, such as contrast-enhanced ultrasonography, may be an effective method of finding ovarian cancer. PURPOSE: This clinical trial is studying how well contrast-enhanced ultrasonography works in diagnosing early-stage ovarian cancer in patients with an adnexal mass undergoing surgery to remove the ovary.

Detailed Study Description

OBJECTIVES: - Determine whether use of a contrast agent improves the images of the ovaries during ultrasonography. OUTLINE: This is a multicenter study. Patients may undergo baseline transabdominal or transvaginal ultrasonography, if not already done. Patients then undergo contrast-enhanced transabdominal or transvaginal ultrasonography using perflutren lipid microspheres (Definity®) IV. Pathology reports from tissue collected during subsequent oophorectomy is analyzed and compared with ultrasonography findings.

Clinical Study Identifier: NCT00626873

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Office - Vanderbilt-Ingram ...

Vanderbilt-Ingram Cancer Center
Nashville, TN United States
  Connect »

Arthur Fleischer

Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, TN United States
  Connect »

Arthur Fleischer

Vanderbilt-Ingram Cancer Center at Franklin
Nashville, TN United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.